TORONTO, March 28, 2025 (GLOBE NEWSWIRE) -- Partners Value Investments Inc. (the “Company”, TSX: PVF.WT, PVF.PR.V) announced today its financial results for the year ended December 31, 2024. All ...

Achieved $3.3 million of net cash provided by operating activities, and our first quarter of positive Free Cash Flow of $3.3 million Achieved positive gross margins of approximately 7% and ...

Boston Omaha Corporation (NYSE: BOC) (the "Company", "we", or "our") announced its financial results for the fiscal year ended December 31, 2024, in connection with filing its Annual Report on Form 10 ...

BOSTON, March 28, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology ...

Acumen Pharmaceuticals Inc (ABOS) reports robust cash reserves and advances in Alzheimer's research, despite increased R&D expenses and competitive challenges.

Spire's restated financials offer clarity amid uncertainty as a legal case impacts its future. Click here to read an analysis of SPIR stock now.

Clene planning to submit a New Drug Application (NDA) in the second half of 2025 for potential Accelerated Approval of CNM-Au8® in ALSClene ...